PASADENA, Calif., June 20, 2023 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science, agtech and advanced technology campuses in AAA innovation cluster locations, has been at the vanguard and heart of the life science ecosystem since inventing and creating the novel Labspace® niche in 1994. Alexandria is a one-of-a-kind company — it is the only pure-play publicly traded laboratory REIT. Founded on the belief that life science companies are most successful when positioned in the epicenter of the world's top innovation ecosystems in close proximity to world-renowned academic medical institutions, deep specialized talent and ample risk capital, Alexandria has applied its cluster model to the life science industry in a disciplined manner to execute on its original bold vision to create a new kind of real estate company uniquely focused on this essential industry and the highly complex infrastructure needed to support its mission-critical work to advance human health. Over the past three decades, Alexandria has strategically and methodically created the highest-quality life science assets concentrated in high-barrier-to-entry markets and built the leading infrastructure platform for the life science industry. The company's execution of its multifaceted platform of internal and external growth continues to drive outstanding long-term total stockholder return (TSR). From its IPO in May 1997 through March 31, 2023, Alexandria has generated an outstanding TSR of 1,444% (assuming reinvestment of dividends), significantly outperforming major indices over the same period, including the Nasdaq Composite's TSR of 998%, the MSCI U.S. REIT's TSR of 706% and the S&P 500's TSR of 683%.